Risk Visualization With Petal-X and Continuous Glucose Monitoring to Support Person-Centered Care and Lifestyle Change in Cardiovascular Prevention: Qualitative Descriptive Study.
Personalized visual displays of cardiovascular risk help patients and healthcare providers communicate better and increase patient engagement in health decisions.
This randomized controlled trial examined Risk Visualization With Petal-X and Continuous Glucose Monitoring to Support Person-Centered Care and Lifestyle Change in Cardiovascular Prevention: Qualitative Descriptive Study. The abstract reports that Patients and nurses reported that personalized visual displays improved understanding of risk factors, facilitated dialogue and shared decision-making, and increased patients' sense of involvement, responsibility, and control, although the 2 groups differed.
What the study was
- Study design
- Randomized controlled trial
- Population
- Human participants
- Category
- Public Health
- Maturity
- Validated
- Journal
- JMIR Hum Factors
Why it surfaced
Randomized controlled trial; directly matches Aging, longevity, and population health. Conservative abstract-level score 9/10.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.